Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ALC Alcon	$86.54 +0.5%	$91.69	$80.48 ▼ $101.10	$42.69B	1.06	1.11 million shs	1.20 million shs
CLPT ClearPoint Neuro	$11.89 -1.6%	$12.80	$5.11 ▼ $19.22	$332.79M	1.03	236,071 shs	172,203 shs
NNOX Nano-X Imaging	$5.13 -2.1%	$5.11	$3.75 ▼ $11.00	$296.41M	2.03	1.74 million shs	745,119 shs
TMCI Treace Medical Concepts	$5.88 -3.6%	$7.23	$4.54 ▼ $10.79	$369.79M	0.79	607,821 shs	400,460 shs

(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ALC Alcon	0.00%	-3.61%	-8.57%	-4.17%	-4.64%
CLPT ClearPoint Neuro	0.00%	-9.79%	-16.79%	-28.89%	+96.20%
NNOX Nano-X Imaging	0.00%	-8.39%	-3.57%	-18.57%	-40.83%
TMCI Treace Medical Concepts	0.00%	-12.50%	-11.71%	-37.25%	+10.32%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ALC Alcon	3.3249 of 5 stars	3.4	5.0	1.7	2.0	0.8	1.3
CLPT ClearPoint Neuro	1.6636 of 5 stars	3.5	2.0	0.0	2.3	0.0	0.6
NNOX Nano-X Imaging	1.3708 of 5 stars	3.5	1.0	0.0	2.0	0.0	0.6
TMCI Treace Medical Concepts	2.2607 of 5 stars	3.1	1.0	0.0	2.3	4.2	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ALC Alcon	2.80	Moderate Buy	$106.13	22.63% Upside
CLPT ClearPoint Neuro	3.00	Buy	$25.00	110.26% Upside
NNOX Nano-X Imaging	3.00	Buy	$9.50	85.19% Upside
TMCI Treace Medical Concepts	2.29	Hold	$10.16	72.74% Upside

Current Analyst Ratings Breakdown

Latest ALC, TMCI, CLPT, and NNOX Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
5/23/2025	NNOX Nano-X Imaging	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$15.00 ➝ $10.00
5/22/2025	NNOX Nano-X Imaging	Alliance Global Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy
5/22/2025	ALC Alcon	Kepler Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
5/20/2025	ALC Alcon	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Hold
5/14/2025	ALC Alcon	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy	$102.00 ➝ $99.00
5/14/2025	ALC Alcon	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$110.00 ➝ $110.00
5/9/2025	TMCI Treace Medical Concepts	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$10.00 ➝ $8.60
4/17/2025	NNOX Nano-X Imaging	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$15.00 ➝ $15.00
4/11/2025	TMCI Treace Medical Concepts	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Hold ➝ Hold	$9.50 ➝ $8.00
4/1/2025	CLPT ClearPoint Neuro	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$19.00 ➝ $25.00
4/1/2025	NNOX Nano-X Imaging	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$12.00 ➝ $9.00

(Data available from 5/25/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ALC Alcon	$9.93B	4.30	$5.02 per share	17.23	$41.81 per share	2.07
CLPT ClearPoint Neuro	$32.24M	10.32	N/A	N/A	$0.86 per share	13.83
NNOX Nano-X Imaging	$11.55M	25.67	N/A	N/A	$3.55 per share	1.45
TMCI Treace Medical Concepts	$210.82M	1.75	N/A	N/A	$2.24 per share	2.63

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ALC Alcon	$974M	$2.25	36.98	26.30	2.29	11.89%	7.17%	5.03%	N/A
CLPT ClearPoint Neuro	-$22.09M	-$0.76	N/A	N/A	N/A	-59.64%	-62.10%	-38.39%	8/6/2025 (Estimated)
NNOX Nano-X Imaging	-$60.78M	-$0.90	N/A	N/A	N/A	-465.38%	-27.63%	-24.72%	N/A
TMCI Treace Medical Concepts	-$49.53M	-$0.85	N/A	N/A	N/A	-30.33%	-51.12%	-26.36%	8/5/2025 (Estimated)

Latest ALC, TMCI, CLPT, and NNOX Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/22/2025	Q1 2025	NNOX Nano-X Imaging	-$0.23	-$0.21	+$0.02	-$0.21	$3.98 million	$3.00 million
5/13/2025	Q1 2025	ALC Alcon	$0.77	$0.73	-$0.04	$0.70	$2.52 billion	$2.33 billion
5/13/2025	Q1 2025	CLPT ClearPoint Neuro	-$0.15	-$0.22	-$0.07	-$0.22	$8.21 million	$8.49 million
5/8/2025	Q1 2025	TMCI Treace Medical Concepts	-$0.31	-$0.25	+$0.06	-$0.25	$52.07 million	$52.57 million
3/31/2025	Q4 2024	NNOX Nano-X Imaging	-$0.15	-$0.23	-$0.08	-$0.23	$3.80 million	$3.00 million
2/26/2025	Q4 2024	CLPT ClearPoint Neuro	-$0.15	-$0.20	-$0.05	-$0.20	$8.23 million	$7.77 million
2/25/2025	Q4 2024	ALC Alcon	$0.70	$0.72	+$0.02	$0.57	$2.47 billion	$2.48 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ALC Alcon	$0.26	0.30%	+33.89%	11.56%	4 Years
CLPT ClearPoint Neuro	N/A	N/A	N/A	N/A	N/A
NNOX Nano-X Imaging	N/A	N/A	N/A	N/A	N/A
TMCI Treace Medical Concepts	N/A	N/A	N/A	N/A	N/A

Latest ALC, TMCI, CLPT, and NNOX Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
4/7/2025	ALC Alcon	annual	$0.3270	0.3%	5/14/2025	5/14/2025	5/15/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ALC Alcon	0.21	2.57	1.60
CLPT ClearPoint Neuro	N/A	4.54	3.61
NNOX Nano-X Imaging	N/A	4.64	4.56
TMCI Treace Medical Concepts	0.51	4.12	2.98

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ALC Alcon	53.86%
CLPT ClearPoint Neuro	30.08%
NNOX Nano-X Imaging	21.49%
TMCI Treace Medical Concepts	84.08%

Insider Ownership

Company	Insider Ownership
ALC Alcon	1.52%
CLPT ClearPoint Neuro	6.97%
NNOX Nano-X Imaging	7.74%
TMCI Treace Medical Concepts	27.72%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ALC Alcon	25,200	493.24 million	N/A	Optionable
CLPT ClearPoint Neuro	110	27.99 million	25.90 million	Optionable
NNOX Nano-X Imaging	190	57.78 million	53.31 million	Optionable
TMCI Treace Medical Concepts	250	62.89 million	47.08 million	Optionable

ALC, TMCI, CLPT, and NNOX Headlines

Recent News About These Companies

Securities Fraud Class Action Filed Against Treace Medical Concepts, Inc. (TMCI) - Levi & Korsinsky Reminds Investors of June 10, 2025

May 25 at 12:07 PM | accessnewswire.com

ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Treace Medical Concepts, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TMCI

May 25 at 12:00 PM | accessnewswire.com

ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Treace Medical Concepts, Inc. ...

May 25 at 10:14 AM | gurufocus.com

Lost Money on Treace Medical Concepts, Inc. (TMCI)? Urged to Join Class Action Before June 10, 2025 - Contact Levi & Korsinsky

May 25 at 10:00 AM | accessnewswire.com

ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Treace Medical Concepts, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – TMCI

May 25 at 9:17 AM | globenewswire.com

Class Action Lawsuit Filed Against Treace Medical Concepts, Inc. (TMCI) - Recover Losses - Contact Levi & Korsinsky Before June 10, 2025

May 25 at 8:47 AM | accessnewswire.com

Class Action Alert: Levi & Korsinsky Reminds Treace Medical Concepts, Inc. (TMCI) Investors of June 10, 2025 Deadline

May 25 at 7:13 AM | accessnewswire.com

TMCI SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Treace Medical Concepts, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

May 25 at 7:00 AM | accessnewswire.com

Jane Street Group LLC Sells 158,845 Shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI)

May 25 at 3:08 AM | marketbeat.com

Class Action Lawsuit Alert: Levi & Korsinsky Reminds Treace Medical Concepts, Inc. (TMCI) Investors of June 10, 2025 Deadline

May 24 at 6:01 PM | accessnewswire.com

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Treace Medical Concepts, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TMCI

May 24 at 5:00 PM | accessnewswire.com

TMCI Investors Have Opportunity to Lead Treace Medical Concepts, Inc. Securities Fraud Lawsuit

May 24 at 3:49 PM | gurufocus.com

TMCI Investors Have Opportunity to Lead Treace Medical Concepts, Inc. Securities Fraud Lawsuit

May 24 at 2:21 PM | prnewswire.com

Point72 Asset Management L.P. Invests $1.41 Million in Treace Medical Concepts, Inc. (NASDAQ:TMCI)

May 24 at 4:14 AM | marketbeat.com

TMCI LAWSUIT ALERT: Levi & Korsinsky Notifies Treace Medical Concepts, Inc. Investors – Lead Plaintiff Deadline June 10, 2025

May 23 at 6:30 PM | accessnewswire.com

TMCI Investors with Large Losses Should Contact Robbins LLP for Information About the Treace Medical Concepts, Inc. Class Action Lawsuit

May 23 at 6:09 PM | globenewswire.com

Class Action Alert: Levi & Korsinsky Reminds Treace Medical Concepts, Inc. (TMCI) Investors of June 10, 2025 Deadline

May 23 at 5:15 PM | accessnewswire.com

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Treace Medical Concepts, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TMCI

May 23 at 5:00 PM | accessnewswire.com

Investors in Treace Medical Concepts, Inc. (TMCI): Protect Your Rights - Contact Levi & Korsinsky Before June 10, 2025

May 23 at 1:15 PM | accessnewswire.com

Investor Alert: Deadline Approaching to Join Treace Medical Concepts, Inc. (TMCI) Class Action - Contact Levi & Korsinsky

May 23 at 12:15 PM | accessnewswire.com

Treace Medical Concepts, Inc. (TMCI) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

May 23 at 12:00 PM | prnewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

Qualcomm Is 5x Cheaper Than AMD, But Won’t Be for Long
By Sam Quirke | May 13, 2025
View Qualcomm Is 5x Cheaper Than AMD, But Won’t Be for Long
Qualcomm’s Re-Entry Into the CPU Market May Not Be Enough
By Thomas Hughes | May 21, 2025
View Qualcomm’s Re-Entry Into the CPU Market May Not Be Enough
Quantum Quandary: Is D-Wave a Calculated Play or Leap of Faith?
By Jeffrey Neal Johnson | May 22, 2025
View Quantum Quandary: Is D-Wave a Calculated Play or Leap of Faith?
Qualcomm: This Week Could Make or Break the Rally
By Sam Quirke | May 19, 2025
View Qualcomm: This Week Could Make or Break the Rally
Qualcomm's Earnings: 2 Reasons to Buy, 1 to Stay Away
By Sam Quirke | May 1, 2025
View Qualcomm's Earnings: 2 Reasons to Buy, 1 to Stay Away

ALC, TMCI, CLPT, and NNOX Company Descriptions

Alcon NYSE:ALC

$86.54 +0.40 (+0.47%)

Closing price 05/23/2025 03:59 PM Eastern

Extended Trading

$86.52 -0.02 (-0.02%)

As of 05/23/2025 05:32 PM Eastern

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, ARGOS biometer, LuxOR surgical ophthalmic microscope, SMARTCATARACT health platform, NGENUITY 3D visualization system, Verion reference unit and Verion digital marker, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantable products, including AcrySof IQ products, such as monofocal IOLs and advanced technology IOLs for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

ClearPoint Neuro NASDAQ:CLPT

$11.89 -0.19 (-1.57%)

Closing price 05/23/2025 04:00 PM Eastern

Extended Trading

$11.90 +0.01 (+0.08%)

As of 05/23/2025 07:43 PM Eastern

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V., UCB Biopharma SRL, and University of California and San Francisco; and development and license agreement with NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

Nano-X Imaging NASDAQ:NNOX

$5.13 -0.11 (-2.10%)

Closing price 05/23/2025 04:00 PM Eastern

Extended Trading

$5.19 +0.06 (+1.25%)

As of 05/23/2025 07:59 PM Eastern

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode. The company's solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source, and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to diagnostic assistive AI systems, billing, and reporting. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists to provide, as well as customers to obtain remote interpretations of imaging data; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data included in images of existing computed tomography scans for osteoporosis and cardiovascular disease; Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities; and multi-specialty physician groups, contracts, and radiology readings. The company is headquartered in Petach Tikva, Israel.

Treace Medical Concepts NASDAQ:TMCI

$5.88 -0.22 (-3.61%)

Closing price 05/23/2025 04:00 PM Eastern

Extended Trading

$5.88 0.00 (0.00%)

As of 05/23/2025 04:46 PM Eastern

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time